ACM
AZN icon

Absolute Capital Management’s AstraZeneca AZN Stock Holding History

Absolute Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-22
Closed -$2.36K – 112
2022
Q3 		$2.36K Buy
+22
New +$2.79K ﹤0.01% 293

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Absolute Capital Management's AZN Position: Q4 2022 in Review

Absolute Capital Management sold out of AstraZeneca (AZN) in Q4 2022, closing a stake of 22 shares — an estimated $2.36K sold.

Absolute Capital Management first reported a position in AZN in Q3 2022 and held it in 1 quarter. The position peaked at $2.36K in Q3 2022. 1,061 funds tracked by Wall St. Rank hold AZN as of Q4 2022.

  • Absolute Capital Management reported no remaining AstraZeneca position as of Q4 2022 after selling out during the quarter.
  • Absolute Capital Management sold 22 AstraZeneca shares in Q4 2022, an estimated $2.36K.
  • Absolute Capital Management first reported a position in AstraZeneca in Q3 2022 and held it in 1 quarter.
  • Absolute Capital Management's AstraZeneca position peaked at $2.36K in Q3 2022.
  • 1,061 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2022.

Based on Absolute Capital Management's 13F filing for Q4 2022, filed 1 Feb 2023.